BACKGROUND: The aim of this study was to investigate the association of body mass index (BMI) with mortality and cardiovascular events in Chinese patients with atrial fibrillation (AF). METHODS AND RESULTS: This study consecutively enrolled AF patients presenting to an emergency department at 20 hospitals in China from November 2008 to October 2011. A total of 2,016 AF patients was enrolled, and patients were categorized as underweight (BMI <18.5), normal (BMI 18.5 to <24), overweight (BMI 24 to <28), and obese (BMI ≥ 28 all kg/m(2)). Multivariate Cox proportional hazards regression was used on all the patients. End points of the analyses were all-cause mortality, cardiovascular mortality, and combined end events. Among overall patients, mean BMI was 23.5 ± 3.6 kg/m(2); 279 (13.8 %) patients died during 12-month follow-up, and so did 23.2 % underweight, 16.3, 9.5 and 9.2 % normal weight, overweight, and obese patients, respectively (P < 0.001). Cardiovascular mortality was 8.3% in all patients, and in underweight, normal weight, overweight and obese categories were 16.5, 9.0, 5.4 and 6.9 %, respectively (P < 0.001). On multivariate analysis, as continuous variable, BMI was not a risk factor for all-cause mortality in AF patients (hazard ratio [HR] 0.94; 95 % confidence interval [CI] 0.91-0.97; P = 0.001). As categorical variable, underweight (HR 1.57, 95 % CI 1.02-2.42, P = 0.041) and normal weight (HR 1.53, 95 % CI 1.13-2.06, P = 0.005) categories were associated with higher all-cause mortality as compared with overweight category. Underweight (HR 2.01, 95 % CI 1.76-3.43, P = 0.011) and normal weight patients (HR 1.53, 95 % CI 1.03-2.28, P = 0.037) also had higher cardiovascular mortality as compared with the overweight category. CONCLUSIONS: Obesity and overweight were not risk factors for 12-month mortality in Chinese AF patients. Overweight AF patients have better survival and outcomes than normal weight (BMI 18.5-24 kg/m(2)) and underweight patients.
BACKGROUND: The aim of this study was to investigate the association of body mass index (BMI) with mortality and cardiovascular events in Chinese patients with atrial fibrillation (AF). METHODS AND RESULTS: This study consecutively enrolled AFpatients presenting to an emergency department at 20 hospitals in China from November 2008 to October 2011. A total of 2,016 AFpatients was enrolled, and patients were categorized as underweight (BMI <18.5), normal (BMI 18.5 to <24), overweight (BMI 24 to <28), and obese (BMI ≥ 28 all kg/m(2)). Multivariate Cox proportional hazards regression was used on all the patients. End points of the analyses were all-cause mortality, cardiovascular mortality, and combined end events. Among overall patients, mean BMI was 23.5 ± 3.6 kg/m(2); 279 (13.8 %) patients died during 12-month follow-up, and so did 23.2 % underweight, 16.3, 9.5 and 9.2 % normal weight, overweight, and obesepatients, respectively (P < 0.001). Cardiovascular mortality was 8.3% in all patients, and in underweight, normal weight, overweight and obese categories were 16.5, 9.0, 5.4 and 6.9 %, respectively (P < 0.001). On multivariate analysis, as continuous variable, BMI was not a risk factor for all-cause mortality in AFpatients (hazard ratio [HR] 0.94; 95 % confidence interval [CI] 0.91-0.97; P = 0.001). As categorical variable, underweight (HR 1.57, 95 % CI 1.02-2.42, P = 0.041) and normal weight (HR 1.53, 95 % CI 1.13-2.06, P = 0.005) categories were associated with higher all-cause mortality as compared with overweight category. Underweight (HR 2.01, 95 % CI 1.76-3.43, P = 0.011) and normal weight patients (HR 1.53, 95 % CI 1.03-2.28, P = 0.037) also had higher cardiovascular mortality as compared with the overweight category. CONCLUSIONS: Obesity and overweight were not risk factors for 12-month mortality in Chinese AFpatients. Overweight AFpatients have better survival and outcomes than normal weight (BMI 18.5-24 kg/m(2)) and underweight patients.
Authors: Gregg C Fonarow; Preethi Srikanthan; Maria Rosa Costanzo; Guillermo B Cintron; Margarita Lopatin Journal: Am Heart J Date: 2007-01 Impact factor: 4.749
Authors: Amy Berrington de Gonzalez; Patricia Hartge; James R Cerhan; Alan J Flint; Lindsay Hannan; Robert J MacInnis; Steven C Moore; Geoffrey S Tobias; Hoda Anton-Culver; Laura Beane Freeman; W Lawrence Beeson; Sandra L Clipp; Dallas R English; Aaron R Folsom; D Michal Freedman; Graham Giles; Niclas Hakansson; Katherine D Henderson; Judith Hoffman-Bolton; Jane A Hoppin; Karen L Koenig; I-Min Lee; Martha S Linet; Yikyung Park; Gaia Pocobelli; Arthur Schatzkin; Howard D Sesso; Elisabete Weiderpass; Bradley J Willcox; Alicja Wolk; Anne Zeleniuch-Jacquotte; Walter C Willett; Michael J Thun Journal: N Engl J Med Date: 2010-12-02 Impact factor: 91.245
Authors: Thure Filskov Overvad; Lars Hvilsted Rasmussen; Flemming Skjøth; Kim Overvad; Gregory Y H Lip; Torben Bjerregaard Larsen Journal: Am J Med Date: 2013-04-17 Impact factor: 4.965
Authors: Thomas J Wang; Martin G Larson; Daniel Levy; Emelia J Benjamin; Eric P Leip; Peter W F Wilson; Ramachandran S Vasan Journal: Circulation Date: 2004-02-10 Impact factor: 29.690
Authors: Teresa S M Tsang; Marion E Barnes; Yoko Miyasaka; Stephen S Cha; Kent R Bailey; Grace C Verzosa; James B Seward; Bernard J Gersh Journal: Eur Heart J Date: 2008-07-08 Impact factor: 29.983
Authors: Carl J Lavie; Martin A Alpert; Ross Arena; Mandeep R Mehra; Richard V Milani; Hector O Ventura Journal: JACC Heart Fail Date: 2013-04-01 Impact factor: 12.035
Authors: Huaibin Wan; Yanmin Yang; Jun Zhu; Xinghui Shao; Juan Wang; Bi Huang; Han Zhang Journal: Medicine (Baltimore) Date: 2015-06 Impact factor: 1.889
Authors: Muhammed Savran; Mesut Engin; Orhan Guvenc; Hasan F Yüksek; Sadık Ahmet Sünbül; Tamer Turk; Yusuf Ata; Ufuk Aydın; Ahmet F Ozyazicioglu Journal: J Saudi Heart Assoc Date: 2021-02-10